CORDRAN CREAM Rx
Generic Name and Formulations:
Flurandrenolide 0.025%, 0.05%.
Indications for CORDRAN CREAM:
Adults and Children:
Apply thin film and massage in 2–3 times daily.
Tape: Serum-exuding lesions. Intertrigo.
Treat infection if present; discontinue if infection persists or worsens. Avoid use near eyes. Systemic absorption increased by more potent steroids, prolonged use, use over large surface area, or use of occlusive dressings. Avoid abrupt cessation in chronic use. Occlude only if necessary; do not occlude higher potency products. Do not use tight-fitting diapers or plastic pants on patients. Do not use on face, groin, or axillae. Monitor adrenal function in children if a high potency product or occlusion is used. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, glucosuria, or irritation occurs. Use lowest effective dose and potency (esp. in children). Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infections, skin atrophy, striae, miliaria, other local effects; immunosuppression, masks infections, intracranial hypertension, HPA axis suppression (esp. in children).
Crm 0.025%—30g, 60g, 120g; Crm 0.05%—15g, 30g, 60g, 120g; Lotion—15mL, 60mL, 120mL; Oint 0.05%—15g, 30g, 60g; Tape (roll) 3in x 24in, 3in x 80in—1
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- The Caregivers' Cancer Journey
- Staff Education Leads to Increase in Oncology Rehabilitation Referrals
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Gender Bias in Medicine Has Far-Reaching Consequences
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Patient Interest in Melanoma Genetic Risk Testing is Fairly High
- Genetic Link Between Depression and Breast Cancer Remains Unclear
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|